Glucagon administration system and methods
US9629901B2 · kind B2 · utility
37Cited by
112References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 1, 2014 |
| Grant date | Apr 25, 2017 |
| Priority date | — |
| Expiry date | Feb 23, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2230/201
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Some embodiments a glucagon administration system can provide a suggested glucagon dosage based on one or more particular parameters (e.g., the user's recent blood glucose characteristics, a glucagon sensitivity value of the user, and other parameters). In some circumstances, the glucagon administration system can receive information indicative of the user's blood glucose level and suggest a glucagon dosage that is at least partially dependent upon a previously stored glucagon sensitivity for the user.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.